Career Advancement

JULY 1, 2019

For example, a multi-billion-dollar biotechnology company recently contacted me for a training on executive presence to help newly minted high-potential mid-level managers reach the next level of leadership. Here’s the program and what the audience learned.

Training 179

Training Execution Biotechnology Audience 179

Career Advancement

SEPTEMBER 27, 2021

“We think, mistakenly, that success is the result of the amount of time we put in at work, instead of the quality of time we put in.” Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. And yet the U.S. Underpromise and overdeliver.

Tips 120

Tips Biotechnology Objective Learning-by-Doing 120

CO2

DECEMBER 15, 2023

In this context, the term ‘best executive coach’ transcends a mere title; it embodies a partnership that fosters transformational growth and strategic success. These studies provide empirical evidence on how executive coaching significantly impacts leadership development, performance, and organizational success.

Executive Coaching 78

Executive Coaching Execution Commitment Biotechnology 78

HR Digest

MAY 14, 2022

The biotechnology company announced Gomez’s appointment as the new Moderna CFO on April 11. The Moderna Success Story. Moderna CFO Jorge Gomez had assumed the position just one day prior, almost a month after leaving a dental company. The Wall Street Journal reported that he will take home nearly $700,000 in severance pay. Moderna Inc.,

CFO 52

CFO Chief Financial Officer Due Diligence Biotechnology 52

First Friday Book Synopsis

MARCH 8, 2011

He has spent most of his professional life as a private research consultant, working primarily in the biotechnology and pharmaceutical industries on research related to mental health. John Medina is a developmental molecular biologist focused on the genes involved in human brain development and the genetics of psychiatric disorders.

Biotechnology 85

Biotechnology Pharmaceuticals Consultative Industry 85

Great Leadership By Dan

JUNE 8, 2017

Guest post from Amy Blankson: In 2013, the National Center for Biotechnology Information reported that the average attention span of a human has dropped to a mere eight seconds , one second behind that of a goldfish. Why does this matter? An interruption as short as 2.8 second interruption can triple error rates.

Management 165

Management Short-term Biotechnology Long-term 165

The Idolbuster

JANUARY 25, 2013

Prior to launching her wellness practice, she worked in the management consulting industry and at one of the leading cancer research biotechnology companies. Catherine Chen, Ph.D., is a Health Coach who supports high-octane professionals to achieve with ease, have time for what they love, and live a balanced life.

Biotechnology 41

Biotechnology Succession How To Follow-up 41

Harvard Business Review

JULY 11, 2018

It’s widely believed that the most successful entrepreneurs are young. However, young people are less common in other industries such as oil and gas or biotechnology, where the average age is closer to 47. But what about the most successful startups? Patricia de Melo Moreira/bloomberg/Getty Images. Among the top 0.1%

Succession 15

Succession IPO Entrepreneur Biotechnology 15

Tanveer Naseer

JUNE 2, 2015

Over the past few weeks, I’ve been writing about the various characteristics and perspectives leaders need to have to be successful in bringing out the best in those they lead. Dan was the president of a biotechnology company where I served in my first middle management role.

Biotechnology 100

Biotechnology Learning-by-Doing Audience Middle Management 100

Skip Prichard

JULY 22, 2019

It’s a fascinating study, one that echoes my constant inquiry of the difference between success and failure. You are teaching what separates successful innovators from those who struggle. If Tesla’s ideas ultimately had more impact, then why was Edison so much more successful? Lessons from Tesla versus Edison.

Innovation 80

Innovation Social Capital Reputation How To 80

N2Growth Blog

FEBRUARY 10, 2021

Genentech is a global biotechnology company that created an entire drug discovery industry. Genentech has been wildly successful. This success has created a virtuous cycle that allows them to attract gifted researchers and scientists from around the world, who can crack the next big genetic sequence.

Tacit Knowledge 296

Tacit Knowledge Biotechnology Sports Wilde 296

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas.

Bureaucracy 203

Bureaucracy Compliance Learning-by-Doing Engineering 203

Harvard Business Review

JUNE 3, 2013

Because succession planning is one of the most important and consequential functions tasked to any board, we wanted to learn more about what boards were doing. Given the boards'' responsibility for succession planning, one would expect them to give the subject plenty of time and consideration. But that''s not the case. Methodology.

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

APRIL 8, 2014

The more you value an idea that you want to spread, the more likely you are to be successful at spreading it. In addition, the more accurately you can predict how others will feel about the message, the more likely you are to be successful at spreading this idea. Do they care about communicating this to their families?

Biotechnology 8

Biotechnology Audience Information Succession 8

The Horizons Tracker

NOVEMBER 29, 2023

We looked at outcomes and found radical innovation when directors had more diverse experience, helping to guide firms toward more cutting-edge exploration and success,” the researchers explain. . “We looked at their experiences and not just their demographic background—the more functional aspect of diversity.

Diversity 98

Diversity Innovation Biotechnology Short-term 98

Harvard Business Review

OCTOBER 26, 2011

Even if most of their investments fail, a few spectacular successes can "make the fund" for a VC. If the IPO window remains open in spite of Solyndra's public failings, we anticipate that a broader set of clean energy startups will achieve successful exits.

Energy 10

Energy Finance IPO Biotechnology 10

Harvard Business Review

JANUARY 5, 2012

For the past few decades, emerging technologies such as biotechnology, microelectronics, information technology and communications technologies have become central to the socioeconomic development of nations. But, in many African countries, the successes afforded by IT can backfire if it becomes a too-dominant focus.

Information Technology 14

Information Technology Technology Information Trends 14

Harvard Business Review

OCTOBER 1, 2014

Indeed, empirical evidence shows that the decline in new business formation is associated with increased per capita income, and the more new businesses countries have, the lower their GDPs are. Most of us who have built or invested in sustainably growing business ventures (as we have) would be thrilled at their survival and growth.

Entrepreneur 11

Entrepreneur Biotechnology Real Estate Innovation 11

Harvard Business Review

JUNE 4, 2018

One approach that has proven to be successful in recent years consists of targeted partnerships between business and education. While many of these jobs are low-paying, many are not, which begs the question: What can be done to better align the unemployed or underemployed with employers that offer good jobs?

Education 8

Education Company Biotechnology Human Capital 8

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. These can be exited at lower multiples, with the trade-off of higher success rates for the R&D-intensive high-multiple investments.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MARCH 13, 2012

Opponents will point out that the discovery of oil and gas can explain a lot of North Dakota's recent success. Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa? Our 50 states have been called laboratories of democracy.

Biotechnology 9

Biotechnology Real Estate Tourism Banking 9

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). Big company innovation success stories like these are inspiring but still far too rare.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

MARCH 1, 2011

And biotechnology and medical devices are among the leading areas for venture capital funding. Very few things in the economy are the same today as they were a half century ago, and most of those are still the same are not considered successes. Fortunes have been made from implants, surgical instruments, and artificial products.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

MARCH 2, 2012

French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology. Their successes globally have created enormous stakeholder value for their customers, employees, communities, and investors.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

MARCH 8, 2013

Hence, one secret to Silicon Valley's success has been its active and visible hand, in stark contrast to the Ayn Rand/Adam Smith folklore often bandied about. It is not by accident that the National Institutes of Health spends $31 billion a year on supporting innovation in biotechnology and pharmacology. government-funded investments.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Strategy Driven

NOVEMBER 18, 2019

When business owners are successful, it’s only natural to start considering how they can make the most of their profits and savings. There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

NOVEMBER 15, 2016

In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices. Lured by Silicon Valley’s ability to help the company scale up faster, he and his team moved to the Bay Area.

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Harvard Business Review

DECEMBER 30, 2011

Organizations invest billions annually on a success curriculum known as "leadership development," which ends up leaving so much on the table. In other words, what if cultivating a successful inner life was front and center on the leadership agenda?

Development 17

Development Biotechnology CIO Short-term 17

Harvard Business Review

FEBRUARY 22, 2013

Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. Realizing that a rejection from the FDA was possible, Baldino sharply scaled back the Mytrophin program, containing the risk but maintaining an option on the possibility of success. The FDA voted to reject Myotrophin in 1997.

Productivity 8

Productivity Products Biotechnology IPO 8

Harvard Business Review

MAY 10, 2016

Helping customers complete their “journey” An example of a stunningly successful merger was Procter & Gamble’s 2005 acquisition of Gillette. By contrast, some of the key players in biotech (Biogen Idec, Amgen, Genentech) have tended to take a more disciplined approach.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

JULY 16, 2013

And 43% cited technology expertise, HR-talent management, international-global expertise, and succession planning as the skills missing most on their boards. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., We also looked at results by industry and region.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

OCTOBER 22, 2013

You may ask, what are some risky investments that stand a high chance of failure but, if successful, enable larger technological leaps that promise earthshaking impact? ups become successful because they are frugal in their origins. Let’s say you’re in the energy sector. They remain resourceful and flexible during growth.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

MARCH 1, 2012

There are still quite a few CMOs around, but most of the truly successful ones aren't American. For example, in biotechnology, a field in which the U.S. Germany certainly did, and its public Fraunhofer Institutions now form the innovation backbone of the world's most successful exporters.

Contract Manufacturing 8

Contract Manufacturing Offshoring Supply Chain Biotechnology 8

Harvard Business Review

OCTOBER 16, 2013

While Silicon Valley continues to dwarf other regions around the world in terms of venture capital investments and successful exits , Case is placing his bets across the rest of America, on what he calls “the rise of the rest.” And there’s the rest of the country where the culture tends to be kind of risk averse.”.

Venture Capitalist 10

Venture Capitalist Company Biotechnology Transportation 10

Tanveer Naseer

OCTOBER 20, 2015

You have the power to bring someone from the slums of life and make a successful person out of them, or destroy someone’s happiness using only your words. With a record like his, it’s not surprising that many people try to use his tactics in the hopes of getting a taste of the levels of success he’s achieved.

Power 100

Power Long-term Uncertainty Biotechnology 100

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. This was a notable success — but what if we combined the insights and resources of a life science company and health provider that were both focused on, say, acute cardiovascular diseases?

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

The Horizons Tracker

DECEMBER 30, 2019

This data was fed into an algorithm that they believe could accurately predict whether a startup would be successful if they decided to up sticks and move to the US. “We If it is a venture capital-oriented IT, hardware or biotechnology company, this destination might be Silicon Valley.”.

Biotechnology 56

Biotechnology Human Capital Travel Entrepreneur 56